Hyperhidrosis

Unexplained mydriasis with cycloplegia in children and teens can cause great parental concern, especially if the patient reports an inability to do schoolwork.

ORLANDO — The efficacy of targeted alkali thermolysis patches for excess sweating may be improved with sweat induction prior to application via a heated room or exercise and with increased exposure times, according to study results.

The FDA has approved Sofdra gel 12.45% for the treatment of primary axillary hyperhidrosis in adults and children aged 9 years and older, Botanix Pharmaceuticals announced in a press release.

It was just another day at school when sophomore Cole Villaflor and his classmates were asked to write on-demand essays in class. As he approached this seemingly easy assignment, his hands began to sweat, dampening the page.

Data show that the COVID-19 pandemic and resulting reorganization of health systems led to a significant reduction in vascular procedures in 2020 and 2021 across Brazil, leading to a $17 million reduction in spending on vascular surgeries.

Journey Medical has entered into an exclusive license agreement with Maruho Co. Ltd. to develop and commercialize Qbrexza in Asia for the treatment of hyperhidrosis, according to a company press release.

The FDA has approved a de novo request for Brella, a noninvasive treatment option for primary axillary hyperhidrosis that utilizes targeted alkali thermolysis technology, Candesant Biomedical announced in a press release.

Topical 20% oxybutynin hydrochloride proved superior to placebo and demonstrated a favorable safety profile in the treatment of primary palmar hyperhidrosis, according to a phase 3 study.

NEW ORLEANS —The targeted alkali thermolysis patch was safe and effective in the treatment of excessive axillary sweating or primary hyperhidrosis in adults, according to data presented at the American Academy of Dermatology Annual Meeting.

Hyperhidrosis is a condition that affects nearly 5% of people, although many go undiagnosed.